The pharmaceutical landscape is witnessing a shift with the introduction of GLP-1 transdermal systems . These exciting formulations offer a possible alternative to administering glucagon-like peptide-1 https://joycekzid044184.blog5.net/92357525/glp-1-patches-a-novel-way-to-manage-diabetes